“Cancer care is evolving rapidly, and collaboration across disciplines and borders has never been more important,” said Michael Reff, RPh, MBA, Founder and Executive Director of NCODA. “The Global Oncology and Haematology Congress is intentionally designed to bring together leaders who are actively reshaping how cancer care is delivered. Sessions will address topics such as sustainable oncology amid global drug shortages, AI-driven cancer care, cardio-oncology, precision medicine, workforce protection, and community-centred models of care. Speaking of the upcoming inaugural congress, Dave Shanahan, NCODA Global Council Steering Committee Member and CEO of Athena Pharmaceuticals, said, “It’s so welcome that an international charity like NCODA has chosen Dublin for their global meeting in 2026, supporting knowledge sharing in the clinical community who deliver cancer care. The robust agenda equips attendees with practical, evidence-based approaches that enhance patient experience and outcomes in everyday practice.”The Global Oncology & Haematology Congress is intentionally structured to encourage thoughtful discussion, showcase real-world innovation, and strengthen partnerships across disciplines and geographies.